Company Filing History:
Years Active: 1999-2013
Title: Ilse De Canck: Innovator in HLA Allele Typing
Introduction
Ilse De Canck is a notable inventor based in Antwerp, Belgium. She has made significant contributions to the field of genetic typing, particularly in the area of HLA alleles. With a total of 3 patents to her name, her work has advanced the understanding and methodologies related to genetic diagnostics.
Latest Patents
Ilse's latest patents focus on methods for typing HLA alleles. One of her inventions discloses the sequence of exon 2 and exon 3 of the alleles HLA-B*3913, HLA-B*1406, and HLA-B*51new, as well as exon 2 of the alleles HLA-DRB1*0820, HLA-DRB1*04new, and HLA-DRB4*01new. The invention provides primers and probes for typing these alleles, along with a diagnostic kit that includes these essential tools. Another patent also relates to the typing of HLA alleles, detailing methods that involve amplifying relevant fragments and hybridizing them to specific probes. This innovative approach enhances the accuracy of genetic testing.
Career Highlights
Throughout her career, Ilse De Canck has worked with prominent companies in the biotechnology sector, including Innogenetics N.V. and N.V. Innogenetics S.A. Her expertise in genetic typing has positioned her as a key figure in the development of diagnostic tools that are crucial for understanding genetic diseases.
Collaborations
Ilse has collaborated with notable professionals in her field, including Rudi Rossau and Guy Mersch. These partnerships have contributed to her success and the advancement of her innovative projects.
Conclusion
Ilse De Canck's contributions to the field of HLA allele typing demonstrate her commitment to advancing genetic diagnostics. Her patents and collaborations reflect her significant impact on the biotechnology industry.